Preview: AIM ImmunoTech’s Earnings
AIM ImmunoTech (AMEX:AIM) is set to give its latest quarterly earnings report on Wednesday, 2023-11-15. Here’s what investors…
AIM ImmunoTech Announces Publication Of Data From Roswell Park Comprehensive Cancer Center Phase 1 Study Evaluating Ampligen As A Component Of A Chemokine-Modulating Regimen In Metastatic Triple-Negative Breast Cancer
AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced the publication of results from the Phase 1 study at Roswell Park Comprehensive Cancer Center in patients with metastatic triple-negative
AIM ImmunoTech Files Definitive Proxy Statement And Sends Letter To Shareholders
November 6, 2023Dear Fellow Shareholders:Thank you for your investment in AIM ImmunoTech ("AIM" or the "Company"). We remain deeply committed to our mission of serving patients and delivering value for you, our
AIM ImmunoTech Engages Business Development Firm, Azenova, LLC To Catalyze Partnering, Development And Commercialization Efforts For Ampligen Pipeline Programs
AIM ImmunoTech Inc. (NYSE:AIM) ("AIM") today announced it has entered into an agreement with Azenova, LLC ("Azenova"), a professional business development (BD) consulting firm, to support efforts to partner AIM's
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today?
AIM ImmunoTech Inc (NYSE: AIM) announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen (rintatolimod) as a component of a Chemokine-Modulating (CKM) regimen for the treatment of early-stage triple-
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Akanda (NASDAQ:AKAN) shares increased by 13.5% to $0.63 during Tuesday’s after-market session. Trading volume for this security…
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
Gainers
BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 23.2% to $4.2 during Friday’s after-market session. The company’s market…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Modular Medical (NASDAQ:MODD) stock rose 33.3% to $1.36 during Wednesday’s after-market session. Trading volume for this security…